Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)

Boni C;Tiseo M;Boni L;Baldini E;Recchia F;Barone C;Grossi F;Germano D;Matano E;Marini G;Labianca R;Di Costanzo F;Bagnulo A;Pennucci C;Caroti C;Mencoboni M;Zanelli F;Prochilo T;Cafferata MA;Ardizzoni A

2012-01-01